Leerink Swann Starts Cyclacel Pharmaceuticals (CYCC) at Outperform; Multiple Opportunities Create Attractive Entry Point

Go back to Leerink Swann Starts Cyclacel Pharmaceuticals (CYCC) at Outperform; Multiple Opportunities Create Attractive Entry Point
CYCLACEL PHARMA (NASDAQ: CYCC) Delayed: 6.37 --0 (-0%)
Previous Close $6.37    52 Week High $9.72 
Open $6.37    52 Week Low $0.30 
Day High $6.37    P/E N/A 
Day Low $6.37    EPS $-2.02 
Volume 48,490